These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1457432)

  • 1. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial.
    Pearl JM; Drinkwater DC; Laks H; Capouya ER; Gates RN
    J Heart Lung Transplant; 1992; 11(6):1082-92. PubMed ID: 1457432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study.
    Roth M; Kraus B; Scheffold T; Reuthebuch O; Klövekorn WP; Bauer EP
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):642-50. PubMed ID: 11003743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of leukocyte depleting filters in heart transplantation: early outcomes in prospective, randomized clinical trial.
    Dvorak L; Pirk J; Cerny S; Kovar J
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):621-7. PubMed ID: 16949830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial.
    Jeevanandam V; Barr ML; Auteri JS; Sanchez JA; Fong J; Schenkel FA; Marboe CC; Michler RE; Smith CR; Rose EA
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):194-8; discussion 198-9. PubMed ID: 1735983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resuscitation of non-beating donor hearts using continuous myocardial perfusion: the importance of controlled initial reperfusion.
    Osaki S; Ishino K; Kotani Y; Honjo O; Suezawa T; Kanki K; Sano S
    Ann Thorac Surg; 2006 Jun; 81(6):2167-71. PubMed ID: 16731148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete functional recovery after 24-hour heart preservation with University of Wisconsin solution and modified reperfusion.
    Stein DG; Permut LC; Drinkwater DC; Bhuta S; Chang P; Wu A; Laks H
    Circulation; 1991 Nov; 84(5 Suppl):III316-23. PubMed ID: 1682070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size.
    Byrne JG; Appleyard RF; Lee CC; Couper GS; Scholl FG; Laurence RG; Cohn LH
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):66-71; discussion 71-2. PubMed ID: 1728716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of leukocyte-depleted blood cardioplegia on the early outcome in patients with preserved left ventricular function undergoing surgical revascularisation.
    Czech B; Frank M; Kucewicz E; Szapiel G; Jackowski R; Gabrylewska A; Busłowska J
    Kardiol Pol; 2005 Jan; 62(1):26-34. PubMed ID: 15815776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 hours.
    Fukushima N; Shirakura R; Nakata S; Kaneko M; Sawa Y; Matsuwaka R; Naka Y; Matsumiya G; Matsuda H
    J Heart Lung Transplant; 1992; 11(4 Pt 1):676-82. PubMed ID: 1498130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenated perfluorocarbon, recombinant human superoxide dismutase, and catalase ameliorate free radical induced myocardial injury during heart preservation and transplantation.
    Bando K; Teramoto S; Tago M; Seno S; Murakami T; Nawa S; Senoo Y
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):930-8. PubMed ID: 3057292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New solution for prolonged myocardial preservation for transplantation.
    Schwalb H; Grinberg L; Yaroslavsky-Houminer E; Lazarovici G; Von Oppell U; Worthington M; Merin G; Borman JB
    J Heart Lung Transplant; 1998 Feb; 17(2):222-9. PubMed ID: 9513861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart.
    Ueda K; Genda T; Hirata I; Shimada M; Shibata T; Ueda T; Omoto R
    J Heart Lung Transplant; 1992; 11(4 Pt 1):646-55. PubMed ID: 1498127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of supplemental L-arginine during warm blood cardioplegia.
    Hayashida N; Tomoeda H; Oda T; Tayama E; Chihara S; Akasu K; Kosuga T; Kai E; Aoyagi S
    Ann Thorac Cardiovasc Surg; 2000 Feb; 6(1):27-33. PubMed ID: 10748356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation.
    Galiñanes M; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):151-8. PubMed ID: 1614201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution.
    Stein DG; Drinkwater DC; Laks H; Permut LC; Sangwan S; Chait HI; Child JS; Bhuta S
    J Thorac Cardiovasc Surg; 1991 Nov; 102(5):657-65. PubMed ID: 1943183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts.
    Kiziltepe U; Tunçtan B; Eyileten ZB; Sirlak M; Arikbuku M; Tasoz R; Uysalel A; Ozyurda U
    Int J Cardiol; 2004 Oct; 97(1):93-100. PubMed ID: 15336814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.
    Kinoshita K; Oe M; Tokunaga K
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of the University of Wisconsin solution over simple crystalloid for extended heart preservation. A study of left ventricular pressure-volume relationship.
    Ko W; Zelano JA; Lazzaro R; Lazenby WD; Hamilton T; Isom OW; Krieger KH
    J Thorac Cardiovasc Surg; 1992 May; 103(5):980-92. PubMed ID: 1569779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.